[1]Guengerich FP. Reactions and significance of cytochrome P-450 enzymes[J]. J Biol Chem, 1991,266(16):10019-10022.
[2]Wienkers LC, Heath TG. Predicting in vivo drug interactions from in intro drug discovery data[J]. Nat Rev Drug Discov, 2005, 4(10): 825-833.
[3]孙 敏,刘 鹏,付晓丽,等.植物成分与细胞色素P450相互作用的研究进展[J]. 药物评价研究. 2012,35(6):465-468.
[4]Totah RA, Rettie AE. Cytochrome P450 2C8: Substrates, inhibitors, pharmacogenetics, and clinical relevance[J]. Clin Pharmacol Ther, 2005, 77 (5): 341-352.
[5]Isoherranen N, Hachad, Yeung CK. Qualitative analysis of the role of metabolites in inhibitory drug-drug interactions: literature evaluation based on the metabolism and transport drug interaction database[J]. Chem Res Toxical, 2009, 22(2): 294-298.
[6]Hengstler JG, Bolt HM. Failure in drug development: the role of inhibition and induction of cytochrome P450 enzymes[J]. Arch Toxicol, 2008, 82 (10):665-666.
[7]Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding[J].Anal Biochem, 1976, 72: 248-254.
[8]Gao N. Effects of baicalin on the pharmacokinetics of liver CYP2E1, CYP1A2 probe drugs in human and rats[D]. Zhengzhou university, 2013.
[9]方艳.人肝微粒体CYP2A6和CYP2C9基因多态性对其药物代谢酶活性的影响[D].硕士学位论文.河南:郑州大学.2014.
[10]李照亮.远志中11个化合物的代谢稳定性及其对CYP450酶活性影响研究[D].硕士学位论文.天津:天津中医药大学.2014.
[11]和 凡,钟国平,赵立予,等.LC-MS/MS法研究黄酮类化合物对人肝微粒体细胞色素P450酶6种亚型的体外抑制作用[J].中国新药杂志,2009,18(24):2340-2344.
[12]Parmentier Y, Bossant MJ, Bertrand M, et al. In vitro studies of drug metabolism[M]. Comprehensive Medicinal ChemistryⅡ-ADME-Tox Approaches. Beijing:Science Press, 2007: 246.
[13]代方国,罗 仁,王宇光,等.甘遂配伍甘草对大鼠肝脏CYP2E1表达及活性的影响[J].第三军医大学学报,2005,27(8):742-744.
[14]高雯,徐文,龚伟玲,等.厚朴提取物对人肝微粒体5种药物代谢酶活性的影响[J].青岛大学医学院学报,2014,50(2):127-129.
[15]Tucker GT, Houston JB, Huang SM. Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential-toward a consensus[J]. Clin Pharmacol Ther, 2001,70(2):103-114.
[16]Yuan C, Liang AJ, Zeng L, et al. Pharmacokinetics profile of magnolol and honokiol in wistar rats[J]. Pharm J Chin PLA, 2003, 19(4): 258-261. |